Arteris, Inc. (NASDAQ:AIP) VP Sells $15,666.76 in Stock

by · The Markets Daily

Arteris, Inc. (NASDAQ:AIP – Get Free Report) VP Paul L. Alpern sold 2,182 shares of the stock in a transaction dated Wednesday, October 2nd. The stock was sold at an average price of $7.18, for a total value of $15,666.76. Following the transaction, the vice president now owns 71,699 shares of the company’s stock, valued at approximately $514,798.82. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link.

Arteris Price Performance

NASDAQ:AIP opened at $7.10 on Friday. Arteris, Inc. has a 52 week low of $4.20 and a 52 week high of $9.54. The company has a debt-to-equity ratio of 0.17, a quick ratio of 1.14 and a current ratio of 1.14. The firm’s 50-day simple moving average is $7.52 and its 200 day simple moving average is $7.64. The firm has a market cap of $273.20 million, a price-to-earnings ratio of -6.89 and a beta of 1.11.

Arteris (NASDAQ:AIP – Get Free Report) last posted its quarterly earnings results on Thursday, August 1st. The company reported ($0.21) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.14) by ($0.07). The firm had revenue of $14.58 million for the quarter, compared to analyst estimates of $13.68 million. Arteris had a negative return on equity of 274.66% and a negative net margin of 68.37%. During the same quarter in the prior year, the business posted ($0.25) EPS. As a group, sell-side analysts predict that Arteris, Inc. will post -0.9 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on the stock. Westpark Capital reiterated a “buy” rating and issued a $11.00 price objective on shares of Arteris in a report on Wednesday, July 31st. Rosenblatt Securities reissued a “buy” rating and set a $15.00 price target on shares of Arteris in a research report on Monday, August 5th.

Check Out Our Latest Stock Analysis on Arteris

Hedge Funds Weigh In On Arteris

Institutional investors have recently modified their holdings of the business. The Manufacturers Life Insurance Company acquired a new position in Arteris during the 2nd quarter worth approximately $86,000. Algert Global LLC bought a new position in shares of Arteris in the 2nd quarter valued at $115,000. Rhumbline Advisers boosted its holdings in shares of Arteris by 2,182.8% during the 2nd quarter. Rhumbline Advisers now owns 31,822 shares of the company’s stock valued at $239,000 after acquiring an additional 30,428 shares in the last quarter. CloudAlpha Capital Management Limited Hong Kong bought a new stake in Arteris during the 2nd quarter worth $554,000. Finally, Bank of New York Mellon Corp acquired a new position in Arteris in the 2nd quarter worth about $580,000. Institutional investors and hedge funds own 64.36% of the company’s stock.

Arteris Company Profile

(Get Free Report)

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.

Featured Articles